TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

600329

CNE000001808

Pharmaceuticals

End-of-day quote Shanghai S.E. Other stock markets 2026-06-12			5-day change	1st Jan Change
38.30 ^CNY	+2.11%		-2.30%	-16.05%

May. 20	Chinese State-Backed Entities to Dispose of Stake in Tianjin Pharmaceutical Da Ren Tang Unit via Public Tender	MT
May. 15	Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Announces Appointment of Zhai Shuping as Independent and Non-Executive Director, Effective May 15, 2026	CI

Tianjin Pharmaceuticals Da Ren Tang's Attributable Profit Jumps 13% in Q1; Shares Up 5%

Published on 04/30/2026 at 02:21 am EDT

MT Newswires

This article is reserved for members

Unlock the article: REGISTER NOW!

100% Free Registration

Already a customer? Log In

Latest news about Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

May. 20	Chinese State-Backed Entities to Dispose of Stake in Tianjin Pharmaceutical Da Ren Tang Unit via Public Tender	MT
May. 15	Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Announces Appointment of Zhai Shuping as Independent and Non-Executive Director, Effective May 15, 2026	CI
May. 15	Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Announces Cessation of Liew Yoke Pheng Joseph as Independnet and Non-Executive Director, Chairman of the Audit Committee and A Member of the Remuneration Committee	CI
Apr. 30	Singapore Shares Surge More Than 1% as DBS Books Record Total Income	MT
Apr. 30	Tianjin Pharmaceuticals Da Ren Tang's Attributable Profit Jumps 13% in Q1; Shares Up 5%	MT
Apr. 29	Tianjin Pharmaceutical Da Ren Tang posts qtrly revenue of RMB1.52 billion	RE
Apr. 29	Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
Mar. 31	Tianjin Pharmaceutical Da Ren Tang's Attributable Profit Drops 4.4% in 2025	MT
Mar. 31	Singapore Shares Remain in Red Amid Soaring Energy Costs; Rex International Plunges 20%	MT
Mar. 30	Tianjin Pharmaceutical Da Ren Tang to Renew Financial Services Agreement with Tianjin Pharmaceutical Group Finance	MT
Mar. 30	Tianjin Pharmaceutical Da Ren Tang's Attributable Profit Down 4% in 2025	MT
Mar. 30	Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Proposes Final Dividend for Fiscal Year 2025	CI
Mar. 30	Tianjin Pharmaceutical Da Ren Tang 2025 net profit down 4.4%	RE
Mar. 30	Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Reports Earnings Results for the Full Year Ended December 31, 2025	CI
Feb. 06	Controlling Shareholder Ups Stake in Tianjin Pharmaceutical Da Ren Tang; Shares Up 3%	MT

Chart Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

Duration

Period

Chart Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

600329: Dynamic Chart

Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd is a China-based company principally engaged in the research, development, manufacturing and retail of Chinese herbal medicines, Chinese patent medicines, chemical raw materials and preparations, and nutritional health products. The Company operates its businesses through three segments. The Chinese Patent Medicine segment is mainly engaged in the research, development, manufacturing and sales of Chinese medicines, including Su Xiao Jiu Xin Pill, Jing Wan Hong Ruan Gao, An Gong Niu Huang Pill, Qing Gong Shou Tao Pill and other products. The Western Medicine segment is mainly engaged in the research, development, manufacturing and sales of Western medicines. The Others segment mainly includes economic information consulting services, house leasing and other businesses. The Company mainly operates its businesses in the domestic and overseas markets.

Employees

3,890

Sector

Pharmaceuticals

More about the company